{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACUT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","market":"US","secType":"STK","nameCN":"Accustem Sciences Inc.","latestPrice":0.886,"timestamp":1750795200000,"preClose":0.901,"halted":0,"volume":1080,"delay":15,"floatShares":9922079,"shares":16182848,"eps":0,"marketStatus":"Pre-Mkt","change":-0.015,"latestTime":"06-24 16:00:00 EDT Delay","open":0.886,"high":0.886,"low":0.886,"amount":953.6155,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750858200000},"marketStatusCode":1,"adr":0,"exchange":"OTCQB","adjPreClose":0.886,"volumeRatio":0.34822981821513566},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","floatShares":9922079,"roa":"-110.75%","roe":"-1794.16%","lyrEps":0,"volumeRatio":0.34822981821513566,"shares":16182848,"dividePrice":0,"high":0.886,"amplitude":0,"preClose":0.901,"low":0.886,"week52Low":0.2159,"pbRate":"-6.65","week52High":1.17,"institutionHeld":0,"latestPrice":0.886,"eps":0,"divideRate":0,"volume":1080,"delay":15,"open":0.886,"prevYearClose":0.448,"prevWeekClose":0.901,"prevMonthClose":0.52,"prevQuarterClose":0.52,"fiveDayClose":1.01,"twentyDayClose":0.508,"sixtyDayClose":0.41},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACUT\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACUT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543263333","title":"Gabriele M. Cerrone, Director and 10% Owner, Reports Acquisition of Common Shares in Accustem Sciences Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2543263333","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543263333?lang=en_us&edition=fundamental","pubTime":"2025-06-13 22:27","pubTimestamp":1749824843,"startTime":"0","endTime":"0","summary":"Gabriele M. Cerrone, a director and 10% owner, reported an acquisition of common shares of Accustem Sciences Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accustem Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL26V6x5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Gabriele M. Cerrone, Director and 10% Owner, Reports Acquisition of Common Shares in Accustem Sciences Ltd","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACUT","BK4139"],"gpt_icon":0},{"id":"2535803687","title":"Accustem Sciences Ltd. Delays Q1 2025 Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2535803687","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535803687?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:46","pubTimestamp":1747341971,"startTime":"0","endTime":"0","summary":"Accustem Sciences Ltd. has announced a delay in filing its financial report for the period ended March 31, 2025. The company has filed a Form 12b-25, indicating a late filing notice for Form 10-Q. The delay is attributed to reasons that could not be resolved without unreasonable effort or expense.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accustem Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL9m9Mxr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACUT"],"gpt_icon":0},{"id":"2530477209","title":"AccuStem Sciences And EmeritusDX Announce Partnership To Commercialize MSC Test For Lung Cancer Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2530477209","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530477209?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:38","pubTimestamp":1745840295,"startTime":"0","endTime":"0","summary":"April 28 (Reuters) - AccuStem Sciences Inc ::*ACCUSTEM SCIENCES, INC. AND EMERITUSDX ANNOUNCE PARTNERSHIP TO COMMERCIALIZE MSC TEST FOR LUNG CANCER SCREENING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 28-APR-202511:00:00.433 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nRSD8TS5Gh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACUT","BK4139"],"gpt_icon":0},{"id":"2529874607","title":"Accustem Sciences, Inc. Announces Chairman Purchase of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529874607?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:00","pubTimestamp":1745233205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nFWN3QZ06D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACUT","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-16","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUT\",market:\"US\",delay:false,,,undefined,":{}}}